Joel Kaye

• Currently responsible for non-clinical pharmacology activities related to Oncology and Inflammation products (Innovative and Biosimilars) across the clinical development pathway (Pre-IND to Phase III and Post Marketing LCM). • Interact in a multidisciplinary matrix environment, coordinating with all functions (Toxicology, ADME/PK, Regulatory, Project Management, Clinical Leaders) • Support all regulatory documentation related to pharmacology.